An Evaluation Of Intra-Cellular Therapies Inc (NASDAQ: ITCI) Prospects

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

Stocks Info

ITCI belongs to the Healthcare sector of the NASDAQ while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Intra-Cellular Therapies Inc is $13.49B. A total of 2.29 million shares were traded on the day, compared to an average of 2.21M shares.

In the most recent transaction, Mates Sharon sold 51,000 shares of ITCI for 85.80 per share on Dec 04 ’24. After the transaction, the Chairman and CEO now owns 1,070,329 company shares. In a previous transaction on Dec 05 ’24, Mates Sharon sold 51,697 shares at 84.08 per share. ITCI shares that Chairman and CEO owns now total 1,070,329.

Among the insiders who bought shares, Mates Sharon acquired of 51,697 shares on Dec 05 ’24 at a per-share price of $84.02. In another insider transaction, Mates Sharon bought 51,000 shares at $85.73 per share on Dec 04 ’24.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ITCI has a high of $128.00 and a low of $62.78.

As of this writing, ITCI has an earnings estimate of -$0.11 per share for the current quarter. EPS was calculated based on a consensus of 12.0 estimates, with a high estimate of $0.22 per share and a lower estimate of -$0.4.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ITCI’s latest balance sheet shows that the firm has $412.33M in Cash & Short Term Investments as of fiscal 2021. There were $25.41M in debt and $53.36M in liabilities at the time. Its Book Value Per Share was $10.80, while its Total Shareholder’s Equity was $417.89M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ITCI is Buy with a score of 3.80.

Most Popular

Related Posts